Original language | English (US) |
---|---|
Article number | e024233 |
Journal | Journal of the American Heart Association |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - Mar 1 2022 |
Keywords
- atrial fibrillation
- clinical trials
- diversity
- gender equity
- leadership
- women
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American Heart Association, Vol. 11, No. 5, e024233, 01.03.2022.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation
AU - Khan, Safi U.
AU - Subramanian, Charumathi Raghu
AU - Khan, Muhammad Zia
AU - Lone, Ahmad N.
AU - Talluri, Swapna
AU - Han, Janet K.
AU - Isakadze, Nino
AU - Volgman, Annabelle Santos
AU - Michos, Erin D.
N1 - Funding Information: Dr Michos is supported by the Amato Fund in Women’s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046. Funding Information: Dr Michos reports advisory boards relationships with AstraZeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. Dr Volgman is supported by the McMullan-Eybel Endowment Chair Fund at Rush University; has served as MSD/Bayer Virtual Global Advisory Board Member; has received support from the Bristol Myers Squibb Foundation Diverse Clinical Investigator Career Development Program (DCICDP); has served on the Novo Nordisk Virtual Advisory Board on Healthcare Disparities, Novartis Clinical Trial, and National Institutes of Health Clinical Trials; and has stock in Apple Inc. Dr Han received speaking honoraria from Abbott, Boston Scientific, and Medtronic. The other authors do not report disclosures. Funding Information: Dr Michos is supported by the Amato Fund in Women?s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046.
PY - 2022/3/1
Y1 - 2022/3/1
KW - atrial fibrillation
KW - clinical trials
KW - diversity
KW - gender equity
KW - leadership
KW - women
UR - http://www.scopus.com/inward/record.url?scp=85125554641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125554641&partnerID=8YFLogxK
U2 - 10.1161/JAHA.121.024233
DO - 10.1161/JAHA.121.024233
M3 - Letter
C2 - 35191324
AN - SCOPUS:85125554641
SN - 2047-9980
VL - 11
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 5
M1 - e024233
ER -